# Levothyroxine sodium

NDC: 0480-8682
Generic name: Levothyroxine sodium
Labeler / Manufacturer: Teva Pharmaceuticals, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20220921
Marketing ended: 20260831
FDA application: ANDA207588

## Active ingredients

- LEVOTHYROXINE SODIUM: 25 ug/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0480-8682"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0480-8682
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=60cadfd7-82b5-4207-97e1-1dd0655efb27